DAVITA INC. Excess Tax Benefit from Share-based Compensation, Financing Activities
DAVITA INC. (DVA) reported Excess Tax Benefit from Share-based Compensation, Financing Activities of $0 for the 12-month period ending 2018-12-31, per its 10-K filed 2019-02-22.
Discontinued › Notes › Compensation Related Costs
us-gaap:ExcessTaxBenefitFromShareBasedCompensationFinancingActivities · last filed 2019-02-22
- DAVITA INC. excess tax benefit from share-based compensation, financing activities for the quarter ending 2016-12-31 was $667.00K, a 92.25% decline year-over-year.
- DAVITA INC. excess tax benefit from share-based compensation, financing activities for the quarter ending 2016-09-30 was $1.98M, a 25.06% decline year-over-year.
- DAVITA INC. excess tax benefit from share-based compensation, financing activities for the quarter ending 2016-06-30 was $6.22M, a 33.32% decline year-over-year.
- DAVITA INC. excess tax benefit from share-based compensation, financing activities for the quarter ending 2016-03-31 was $4.38M, a 42.21% decline year-over-year.
- DAVITA INC. excess tax benefit from share-based compensation, financing activities for fiscal 2018 was $0.00.
- DAVITA INC. excess tax benefit from share-based compensation, financing activities for fiscal 2017 was $0.00, a 100.00% decline from fiscal 2016.
- DAVITA INC. excess tax benefit from share-based compensation, financing activities for fiscal 2016 was $13.25M, a 52.94% decline from fiscal 2015.
- DAVITA INC. excess tax benefit from share-based compensation, financing activities for fiscal 2015 was $28.16M, a 37.80% decline from fiscal 2014.
| Period end | Excess Tax Benefit from Share-based Compensation, Financing Activities 3 month | Excess Tax Benefit from Share-based Compensation, Financing Activities 6 month | Excess Tax Benefit from Share-based Compensation, Financing Activities 9 month | Excess Tax Benefit from Share-based Compensation, Financing Activities 12 month |
|---|---|---|---|---|
| 2018-12-31 | $0.00 10-K · filed 2019-02-22 | |||
| 2017-12-31 | $0.00 10-K · filed 2019-02-22 | |||
| 2016-12-31 | $667.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-22 | $2.65M derived: sum of 2 quarters · filed 2019-02-22 | $8.87M derived: sum of 3 quarters · filed 2019-02-22 | $13.25M 10-K · filed 2019-02-22 |
| 2016-09-30 | $1.98M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-02 | $8.20M derived: sum of 2 quarters · filed 2016-11-02 | $12.58M 10-Q · filed 2016-11-02 | $21.19M derived: sum of 4 quarters · filed 2018-02-23 |
| 2016-06-30 | $6.22M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08 | $10.60M 10-Q · filed 2016-08-08 | $19.21M derived: sum of 3 quarters · filed 2018-02-23 | $21.85M derived: sum of 4 quarters · filed 2018-02-23 |
| 2016-03-31 | $4.38M 10-Q · filed 2016-05-04 | $12.98M derived: sum of 2 quarters · filed 2018-02-23 | $15.63M derived: sum of 3 quarters · filed 2018-02-23 | $24.96M derived: sum of 4 quarters · filed 2018-02-23 |
| 2015-12-31 | $8.60M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-23 | $11.24M derived: sum of 2 quarters · filed 2018-02-23 | $20.57M derived: sum of 3 quarters · filed 2018-02-23 | $28.16M 10-K · filed 2018-02-23 |
| 2015-09-30 | $2.64M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-02 | $11.97M derived: sum of 2 quarters · filed 2016-11-02 | $19.55M 10-Q · filed 2016-11-02 | $32.16M derived: sum of 4 quarters · filed 2017-02-24 |
| 2015-06-30 | $9.33M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08 | $16.91M 10-Q · filed 2016-08-08 | $29.52M derived: sum of 3 quarters · filed 2017-02-24 | $31.95M derived: sum of 4 quarters · filed 2017-02-24 |
| 2015-03-31 | $7.58M 10-Q · filed 2016-05-04 | $20.19M derived: sum of 2 quarters · filed 2017-02-24 | $22.62M derived: sum of 3 quarters · filed 2017-02-24 | $34.52M derived: sum of 4 quarters · filed 2017-02-24 |
| 2014-12-31 | $12.61M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-24 | $15.03M derived: sum of 2 quarters · filed 2017-02-24 | $26.93M derived: sum of 3 quarters · filed 2017-02-24 | $45.27M 10-K · filed 2017-02-24 |
| 2014-09-30 | $2.43M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05 | $14.33M derived: sum of 2 quarters · filed 2015-11-05 | $32.66M 10-Q · filed 2015-11-05 | $37.14M derived: sum of 4 quarters · filed 2016-02-26 |
| 2014-06-30 | $11.90M derived: 10-Q 6 month − 10-Q/A 3 month · filed 2015-08-05 | $30.24M 10-Q · filed 2015-08-05 | $34.71M derived: sum of 3 quarters · filed 2016-02-26 | $37.99M derived: sum of 4 quarters · filed 2016-02-26 |
| 2014-03-31 | $18.34M 10-Q/A · filed 2015-05-08 | $22.81M derived: sum of 2 quarters · filed 2016-02-26 | $26.09M derived: sum of 3 quarters · filed 2016-02-26 | $47.58M derived: sum of 4 quarters · filed 2016-02-26 |
| 2013-12-31 | $4.47M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-26 | $7.75M derived: sum of 2 quarters · filed 2016-02-26 | $29.24M derived: sum of 3 quarters · filed 2016-02-26 | $36.20M 10-K · filed 2016-02-26 |
| 2013-09-30 | $3.28M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06 | $24.77M derived: sum of 2 quarters · filed 2014-11-06 | $31.72M 10-Q · filed 2014-11-06 | $54.41M derived: sum of 4 quarters · filed 2015-02-26 |
| 2013-06-30 | $21.48M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-01 | $28.44M 10-Q · filed 2014-08-01 | $51.13M derived: sum of 3 quarters · filed 2015-02-26 | $75.64M derived: sum of 4 quarters · filed 2015-02-26 |
| 2013-03-31 | $6.96M 10-Q · filed 2014-05-02 | $29.65M derived: sum of 2 quarters · filed 2015-02-26 | $54.15M derived: sum of 3 quarters · filed 2015-02-26 | $62.89M derived: sum of 4 quarters · filed 2015-02-26 |
| 2012-12-31 | $22.69M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-26 | $47.20M derived: sum of 2 quarters · filed 2015-02-26 | $55.94M derived: sum of 3 quarters · filed 2015-02-26 | $62.04M 10-K · filed 2015-02-26 |
| 2012-09-30 | $24.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-06 | $33.24M derived: sum of 2 quarters · filed 2013-11-06 | $39.35M 10-Q · filed 2013-11-06 | $40.54M derived: sum of 4 quarters · filed 2014-02-21 |
| 2012-06-30 | $8.74M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-07 | $14.84M 10-Q · filed 2013-08-07 | $16.04M derived: sum of 3 quarters · filed 2014-02-21 | $16.67M derived: sum of 4 quarters · filed 2014-02-21 |
| 2012-03-31 | $6.10M 10-Q · filed 2013-05-09 | $7.29M derived: sum of 2 quarters · filed 2014-02-21 | $7.93M derived: sum of 3 quarters · filed 2014-02-21 | $19.74M derived: sum of 4 quarters · filed 2014-02-21 |
| 2011-12-31 | $1.19M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-21 | $1.82M derived: sum of 2 quarters · filed 2014-02-21 | $13.64M derived: sum of 3 quarters · filed 2014-02-21 | $20.83M 10-K · filed 2014-02-21 |
| 2011-09-30 | $631.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-10-31 | $12.44M derived: sum of 2 quarters · filed 2012-10-31 | $19.64M 10-Q · filed 2012-10-31 | $23.84M derived: sum of 4 quarters · filed 2013-03-01 |
| 2011-06-30 | $11.81M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-03 | $19.01M 10-Q · filed 2012-08-03 | $23.21M derived: sum of 3 quarters · filed 2013-03-01 | $23.64M derived: sum of 4 quarters · filed 2013-03-01 |
| 2011-03-31 | $7.20M 10-Q · filed 2012-05-02 | $11.40M derived: sum of 2 quarters · filed 2013-03-01 | $11.83M derived: sum of 3 quarters · filed 2013-03-01 | $12.10M derived: sum of 4 quarters · filed 2013-03-01 |
| 2010-12-31 | $4.20M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-01 | $4.64M derived: sum of 2 quarters · filed 2013-03-01 | $4.91M derived: sum of 3 quarters · filed 2013-03-01 | $6.28M 10-K · filed 2013-03-01 |
| 2010-09-30 | $432.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-04 | $701.00K derived: sum of 2 quarters · filed 2011-11-04 | $2.08M 10-Q · filed 2011-11-04 | $914.00K derived: sum of 4 quarters · filed 2012-07-06 |
| 2010-06-30 | $269.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-04 | $1.65M 10-Q · filed 2011-08-04 | $482.00K derived: sum of 3 quarters · filed 2012-07-06 | $1.01M derived: sum of 4 quarters · filed 2012-07-06 |
| 2010-03-31 | $1.38M 10-Q · filed 2011-05-06 | $213.00K derived: sum of 2 quarters · filed 2012-07-06 | $737.00K derived: sum of 3 quarters · filed 2012-07-06 | $7.55M derived: sum of 4 quarters · filed 2012-07-06 |
| 2009-12-31 | -$1.17M derived: 8-K 12 month − 10-Q 9 month · filed 2012-07-06 | -$641.00K derived: sum of 2 quarters · filed 2012-07-06 | $6.17M derived: sum of 3 quarters · filed 2012-07-06 | $6.95M 8-K · filed 2012-07-06 |
| 2009-09-30 | $524.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2010-11-05 | $7.34M derived: sum of 2 quarters · filed 2010-11-05 | $8.12M 10-Q · filed 2010-11-05 | $11.07M derived: sum of 4 quarters · filed 2011-02-25 |
| 2009-06-30 | $6.81M derived: 10-Q 6 month − 10-Q 3 month · filed 2010-08-05 | $7.59M 10-Q · filed 2010-08-05 | $10.55M derived: sum of 3 quarters · filed 2011-02-25 | $12.55M derived: sum of 4 quarters · filed 2011-02-25 |
| 2009-03-31 | $779.00K 10-Q · filed 2010-05-03 | $3.74M derived: sum of 2 quarters · filed 2011-02-25 | $5.74M derived: sum of 3 quarters · filed 2011-02-25 | |
| 2008-12-31 | $2.96M derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-25 | $4.96M derived: sum of 2 quarters · filed 2011-02-25 | $8.01M 10-K · filed 2011-02-25 | |
| 2008-09-30 | $2.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2009-11-05 | $5.05M 10-Q · filed 2009-11-05 | ||
| 2008-06-30 | $3.06M 10-Q · filed 2009-08-07 | |||
| 2007-12-31 | $25.54M 10-K · filed 2010-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |